# Denosumab (Genetical Recombination) [Denosumab Biosimilar 1] S.C. Injection 120mgRM "F" (デノスマブＢＳ皮下注１２０ｍｇＲＭ「Ｆ」)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 3999478A1029). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 3999478A1029
- **Product name (Japanese):** デノスマブＢＳ皮下注１２０ｍｇＲＭ「Ｆ」
- **Product name (English):** Denosumab (Genetical Recombination) [Denosumab Biosimilar 1] S.C. Injection 120mgRM "F"
- **Active ingredient:** デノスマブ（遺伝子組換え）［デノスマブ後続１］
- **Active ingredient (INN):** Denosumab (Genetical Recombination) [Denosumab Biosimilar 1]
- **Strength / unit:** １２０ｍｇ１．７ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 39 Other metabolic agents (その他の代謝性医薬品) › 399 Other metabolic agents (n.e.c.) (他に分類されない代謝性医薬品)
- **Manufacturer:** Fuji Pharma (富士製薬工業)
- **Brand / generic:** Generic (後発医薬品)
- **NHI price (reference only):** JPY 23481 per １２０ｍｇ１．７ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/3999478A1029
- **JSON:** https://www.nifujipharma.com/api/drugs/3999478A1029

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Denosumab%20(Genetical%20Recombination)%20%5BDenosumab%20Biosimilar%201%5D%20S.C.%20Injection%20120mgRM%20%22F%22%20(%E3%83%87%E3%83%8E%E3%82%B9%E3%83%9E%E3%83%96%EF%BC%A2%EF%BC%B3%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%91%EF%BC%92%EF%BC%90%EF%BD%8D%EF%BD%87%EF%BC%B2%EF%BC%AD%E3%80%8C%EF%BC%A6%E3%80%8D)%20%2F%20YJ%203999478A1029#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.